{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T07:00:52Z","timestamp":1764745252206,"version":"3.46.0"},"reference-count":15,"publisher":"Touch Medical Media, Ltd.","issue":"1","license":[{"start":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:00:00Z","timestamp":1518739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"This article is published under the Creative Commons Attribution Non-commercial License."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"abstract":"","DOI":"10.17925\/hi.2020.14.1.16","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T03:34:46Z","timestamp":1598931286000},"page":"16","source":"Crossref","is-referenced-by-count":4,"title":["Cardiovascular Effects of COVID-19 \u2013 What Do We Know and Where Should We Go?"],"prefix":"10.17925","volume":"14","author":[{"given":"Matthew","family":"Ryan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"School of Cardiovascular Medicine and Sciences, British Heart Foundation Centre of Excellence and National Institute for Health Research (NIHR) Biomedical Research Centre, King\u2019s College London, London, UK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozan","family":"Demir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"School of Cardiovascular Medicine and Sciences, British Heart Foundation Centre of Excellence and National Institute for Health Research (NIHR) Biomedical Research Centre, King\u2019s College London, London, UK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"O\u2019Gallagher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"School of Cardiovascular Medicine and Sciences, British Heart Foundation Centre of Excellence and National Institute for Health Research (NIHR) Biomedical Research Centre, King\u2019s College London, London, UK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divaka","family":"Perera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"School of Cardiovascular Medicine and Sciences, British Heart Foundation Centre of Excellence and National Institute for Health Research (NIHR) Biomedical Research Centre, King\u2019s College London, London, UK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7274","reference":[{"key":"ref1","unstructured":"World Health Organisation. Global research on coronavirus disease (COVID-19). 2020. Available at: www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov (accessed 20 May 2020)."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Hua A, O'Gallagher K, Sado D, Byrne J. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19.\n Eur Heart J\n . 2020;41:2130.","DOI":"10.1093\/eurheartj\/ehaa253"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Verity R, Okell LC, Dorigatti L, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis.\n Lancet\n . 2020;20:669\u201377.","DOI":"10.1016\/S1473-3099(20)30243-7"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention.\n JAMA\n . 2020;323:1239\u201342.","DOI":"10.1001\/jama.2020.2648"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Kreutz R, Algharably EAE-H, Azizi M, et al. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.\n Cardiovasc Res\n . 2020;116:1688\u201399.","DOI":"10.1093\/cvr\/cvaa097"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.\n Lancet\n . 2020;395:1054\u201362.","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Santoso A, Pranata R, Wibowo A, et al. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: a meta-analysis.\n Am J Emerg Med\n . 2020; doi:10.1016\/j.ajem.2020.04.052 [Online ahead of print].","DOI":"10.1016\/j.ajem.2020.04.052"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Tang X, Du R, Wang R, et al. Comparison of hospitalized patients with ARDS caused by COVID-19 and H1N1.\n Chest\n . 2020;158:195\u2013205.","DOI":"10.1016\/j.chest.2020.03.032"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Li Y, Li H, Zhu S, et al. Prognostic value of right ventricular longitudinal strain in patients with COVID-19.\n JACC Cardiovasc Imaging\n . 2020;doi:10.1016\/j.jcmg.2020.04.014 [Online ahead of print]","DOI":"10.1016\/j.jcmg.2020.04.014"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Vaduganathan M, Vardeny O, Michel T, et al. Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19.\n N Engl J Med\n . 2020;382:1653\u20139.","DOI":"10.1056\/NEJMsr2005760"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Zhang P, Zhu L, Cai J, et al. Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers with mortality among patients with hypertension hospitalized with COVID-19.\n Circ Res\n . 2020;126:1671\u201381.","DOI":"10.1161\/CIRCRESAHA.120.317134"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19.\n Lancet\n . 2020;395:1417\u20138.","DOI":"10.1016\/S0140-6736(20)30937-5"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Bangalore S, Sharma A, Slotwiner A, et al. ST-segment elevation in patients with COVID-19 - a case series.\n N Engl J Med\n . 2020;382:2478\u201380.","DOI":"10.1056\/NEJMc2009020"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-segment elevation cardiac catherization laboratory activations in the United States during COVID-19 pandemic.\n J Am Coll Cardiol\n . 2020;75:2871\u20132.","DOI":"10.1016\/j.jacc.2020.04.011"},{"key":"ref15","unstructured":"European Society of Cardiology. ESC guidelines for the diagnosis and management of CV disease during the COVID-19 pandemic. 2020. Available at: www.escardio.org\/Education\/COVID-19-and-Cardiology\/ESC-COVID-19-Guidance (accessed 20 May 2020)."}],"container-title":["Heart International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/touchcardio.com\/covid-19\/journal-articles\/96-impact-of-covid-19-on-ventricular-tachycardia-and-atrial-tachycardia-events-in-patients-with-transvenous-devices\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:58:31Z","timestamp":1764745111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.touchcardio.com\/covid-19\/journal-articles\/cardiovascular-effects-of-covid-19-what-do-we-know-and-where-should-we-go\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["HI.2020.14.1.16"],"URL":"https:\/\/doi.org\/10.17925\/hi.2020.14.1.16","relation":{},"ISSN":["2036-2579"],"issn-type":[{"type":"print","value":"2036-2579"}],"subject":[],"published":{"date-parts":[[2020]]}}}